Michael A. Moore

1.4k total citations
28 papers, 948 citations indexed

About

Michael A. Moore is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A. Moore has authored 28 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A. Moore's work include Blood Pressure and Hypertension Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Chronic Kidney Disease and Diabetes (3 papers). Michael A. Moore is often cited by papers focused on Blood Pressure and Hypertension Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Chronic Kidney Disease and Diabetes (3 papers). Michael A. Moore collaborates with scholars based in United States, Canada and Ireland. Michael A. Moore's co-authors include Sjirk J. Westra, Sharon M. Moe, Ellie Kelepouris, Grace L. Smith, Mark Mitsnefes, Frank C. Brosius, Subramaniam Pennathur, Peter W.F. Wilson, Thomas H. Hostetter and W. Gordon Walker and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Michael A. Moore

28 papers receiving 878 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael A. Moore 344 234 223 169 157 28 948
Arturo Carratalá 528 1.5× 232 1.0× 91 0.4× 103 0.6× 253 1.6× 56 1.1k
Iris Kingma 685 2.0× 244 1.0× 79 0.4× 372 2.2× 251 1.6× 39 1.4k
Claudio Picariello 659 1.9× 194 0.8× 102 0.5× 117 0.7× 79 0.5× 68 973
Marco Moltrasio 574 1.7× 186 0.8× 185 0.8× 525 3.1× 136 0.9× 40 1.1k
Hirotake Okazaki 454 1.3× 193 0.8× 79 0.4× 214 1.3× 196 1.2× 67 840
Gaetano Ruocco 668 1.9× 191 0.8× 97 0.4× 203 1.2× 293 1.9× 75 1.0k
Muhammed Keskin 634 1.8× 262 1.1× 154 0.7× 100 0.6× 162 1.0× 90 1.1k
Valentina Milazzo 513 1.5× 170 0.7× 86 0.4× 171 1.0× 101 0.6× 39 867
Nadia Aspromonte 1.0k 2.9× 312 1.3× 101 0.5× 116 0.7× 171 1.1× 129 1.5k
Kenechukwu Mezue 659 1.9× 196 0.8× 79 0.4× 264 1.6× 236 1.5× 44 1.2k

Countries citing papers authored by Michael A. Moore

Since Specialization
Citations

This map shows the geographic impact of Michael A. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Moore more than expected).

Fields of papers citing papers by Michael A. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Moore. The network helps show where Michael A. Moore may publish in the future.

Co-authorship network of co-authors of Michael A. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Moore. A scholar is included among the top collaborators of Michael A. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Moore. Michael A. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edelstein, Adam I., Mary Kwasny, Linda I. Suleiman, et al.. (2015). Can the American College of Surgeons Risk Calculator Predict 30-Day Complications After Knee and Hip Arthroplasty?. The Journal of Arthroplasty. 30(9). 5–10. 110 indexed citations
2.
Moore, Michael A., et al.. (2011). Chest Trauma in Children: Current Imaging Guidelines and Techniques. Radiologic Clinics of North America. 49(5). 949–968. 17 indexed citations
3.
4.
Singh, Sarabjeet, Mannudeep K. Kalra, Michael A. Moore, et al.. (2009). Dose Reduction and Compliance with Pediatric CT Protocols Adapted to Patient Size, Clinical Indication, and Number of Prior Studies. Radiology. 252(1). 200–208. 154 indexed citations
5.
Moore, Michael A., et al.. (2009). The imaging of paediatric thoracic trauma. Pediatric Radiology. 39(5). 485–496. 35 indexed citations
6.
Moore, Michael A., et al.. (2009). The Impact of Changing ICD Code on Hypertension‐Related Mortality in the Southeastern United States from 1994–2005. Journal of Clinical Hypertension. 12(3). 213–222. 4 indexed citations
7.
Brosius, Frank C., Thomas H. Hostetter, Ellie Kelepouris, et al.. (2006). Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease. Circulation. 114(10). 1083–1087. 240 indexed citations
8.
Houston, Mark C., Ralph G. Hawkins, Jan Basile, et al.. (2005). Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, and Insulin Resistance in the Southeastern United States. The American Journal of the Medical Sciences. 329(6). 276–291. 40 indexed citations
9.
Moore, Michael A.. (2003). Drugs That Interrupt the Renin‐Angiotensin System Should Be Among the Preferred Initial Drugs to Treat Hypertension. Journal of Clinical Hypertension. 5(2). 137–144. 10 indexed citations
10.
Moore, Michael A.. (2002). Improving the Managed Care of Hypertension with Angiotensin II Antagonists. The American Journal of the Medical Sciences. 323(1). 25–33. 3 indexed citations
11.
Moore, Michael A., et al.. (2001). Gene Therapy to Control Hypertension: Current Studies and Future Perspectives. The American Journal of the Medical Sciences. 322(1). 1–6. 4 indexed citations
12.
Moore, Michael A. & Ernesto L. Schiffrin. (2001). Small Artery Remodeling in Hypertension: Can It Be Corrected?. The American Journal of the Medical Sciences. 322(1). 7–11. 22 indexed citations
13.
Moore, Michael A.. (2001). Choosing Initial Antihypertensive Drug Therapy for the Uncomplicated Hypertensive Patient. Journal of Clinical Hypertension. 3(1). 37–44. 4 indexed citations
14.
Moore, Michael A., et al.. (1999). Current Strategies for Management of Hypertensive Renal Disease. Archives of Internal Medicine. 159(1). 23–23. 17 indexed citations
15.
Jennette, J. Charles, et al.. (1982). IgA nephropathy associated with seronegative spondylarthropathies. Arthritis & Rheumatism. 25(2). 144–149. 43 indexed citations
16.
Cooke, Colin R., et al.. (1979). Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects. Kidney International. 15(6). 669–675. 10 indexed citations
17.
Moore, Michael A., et al.. (1977). Reversible Renal Hypertension Secondary to Renal Arteriovenous Fistula and Renal Cell Carcinoma. The Journal of Urology. 117(2). 246–247. 3 indexed citations
18.
Moore, Michael A., et al.. (1977). The characteristics and mortality of outpatient-acquired pneumonia.. PubMed. 140(1). 9–14. 30 indexed citations
19.
Walker, W. Gordon, Michael A. Moore, John S. Horvath, & Paul K. Whelton. (1976). Arterial and venous angiotensin II in normal subjects. Relation to plasma renin activity and plasma aldosterone concentration, and response to posture and volume changes.. Circulation Research. 38(6). 477–483. 22 indexed citations
20.
Cooke, Colin R., John S. Horvath, Michael A. Moore, T.J. Bledsoe, & W. Gordon Walker. (1973). Modulation of Plasma Aldosterone Concentration by Plasma Potassium in Anephric Man in the Absence of a Change in Potassium Balance. Journal of Clinical Investigation. 52(12). 3028–3032. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arturo Carratalá Breakdown of academic impact, for papers by Iris Kingma Breakdown of academic impact, for papers by Claudio Picariello Breakdown of academic impact, for papers by Marco Moltrasio Breakdown of academic impact, for papers by Hirotake Okazaki Breakdown of academic impact, for papers by Gaetano Ruocco Breakdown of academic impact, for papers by Muhammed Keskin Breakdown of academic impact, for papers by Valentina Milazzo Breakdown of academic impact, for papers by Nadia Aspromonte Breakdown of academic impact, for papers by Kenechukwu Mezue
Rankless by CCL
2026